CNL NSI Week ended 31 Jul 2026

Weekly Investor Report

Creative Newtech Limited · Technology · Electronics & Computer Distribution

Open interactive chart View report data
Latest close 993.2 INR
0.6% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 43.5% above the Trend Line and sits at 84.3% of its 52-week range. The latest completed week returned 0.6%, after a 29.9% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 51/100.

Setup score 65 out of 100
Latest Close 993.2 INR 31 Jul 2026
1W Return 0.6% latest completed week
4W Return 29.9% short-term follow-through
12W Return 57.2% quarterly tape
Trend Breadth 11.4% 4 of 35 weeks active
Volume Ratio 2.5x vs 13-week average
What is working
  • The trend backdrop is active with a 4-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 5 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.6% Latest completed week; four-week move 29.9%. Indicator stack 20/88 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 72.02% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 51/100 16 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 43.5% above the Trend Line and sits at 84.3% of its 52-week range. The latest completed week returned 0.6%, after a 29.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 2.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4912-week average 0.19

12-week confirmation

Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.49Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers55 reversal markers

No recent accumulation markers. 5 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 29.9% over four weeks, 57.2% over 12 weeks, and - over one year. The current trend has remained active for 4 consecutive weeks.

Performance by holding period

1W0.6%
4W29.9%
12W57.2%
26W45.5%
52W-
Active trend streak4 weeks
Active weeks in one year4
Trend breadth11.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.91Latest activity-pressure read.
Pressure change42.3%Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 85% Model confidence 81%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength23/100Blend of value, momentum, and quality. Underlying universe rank 78; rank 1 is best.
Value40/100Relative valuation strength. Underlying universe rank 61; rank 1 is best.
Quality14/100Profitability and accounting quality. Underlying universe rank 87; rank 1 is best.
Momentum61/100Medium-term price momentum. Underlying universe rank 40; rank 1 is best.
Growth92/100Revenue and earnings growth. Underlying universe rank 9; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework51/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
21.5x
Price divided by trailing earnings.
Price / sales
0.5x
Market value relative to trailing revenue.
EV / EBITDA
17.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-15.1%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
7.9%
Gross profit retained from each unit of revenue.
Operating margin
3.3%
Operating profit retained from revenue.
Free-cash-flow margin
-10.2%
Free cash flow generated from revenue.
Return on invested capital
9.8%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
52.1%
Latest one-year revenue growth.
EPS growth
32.4%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-1551.5%
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.1%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment51/100

Weighted news tone is neutral across 16 relevant articles.

1 positive · 15 neutral · 0 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-8.1%Distance below the 52-week high.
13-week volatility4.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher17 of 269 weeks finished lower.
Best week+11.8%Week of 12 Jun.
Worst week-7.9%Week of 20 Mar.
Latest week+0.6%Week of 31 Jul.

Shape of recent returns

Strong gains8
Modest gains9
Flat weeks0
Modest losses6
Sharp losses3
Recent vol4.6%13-week weekly-return volatility.
Base vol4.8%52-week weekly-return volatility.
Up/down split19/15Count of positive and negative weeks in the 52-week window.
Average skew4.4% / -3.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape57/100

Trend, activity pressure, participation, and risk combine to a 57/100 tape read.

 Indicator analysis30/100

Latest 12-week confirmation: trend 4/12, activity pressure 7/12, relative leadership 0/12.

Activity pressure 0.49; 5 reversal markers Next-Week ExpectancyPositive 72.02%

Next-week expectancy is positive with a 72.02% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors32/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 17; Small Cap Core rank 45 SVQF51/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 785.5 of 1590 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment51/100

Weighted news tone is neutral across 16 relevant articles.

Creative Newtech to acquire Infinova India for USD 4 million Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026993.2 INR0.6%692.0 INR698.8 INR1.91-3.0MOn
24 Jul 2026987.0 INR7.7%683.2 INR690.2 INR1.84-5.8MOn
17 Jul 2026916.5 INR8.1%675.1 INR681.2 INR1.64-2.5MOn
10 Jul 2026847.5 INR10.8%669.3 INR673.8 INR1.58-3.9MOn
3 Jul 2026764.6 INR4.5%667.1 INR668.2 INR1.35-76.3KOff
26 Jun 2026731.6 INR-2.9%665.0 INR665.0 INR1.04-0Off
19 Jun 2026753.2 INR6.8%-662.7 INR0.74-119.0KOff
12 Jun 2026705.0 INR11.8%-659.5 INR--14.3KOff
5 Jun 2026630.7 INR0.3%-657.8 INR--7.5KOff
29 May 2026628.5 INR-2.0%-658.8 INR--35.8KOff
22 May 2026641.2 INR0.7%-660.1 INR--69.7KOff
15 May 2026637.0 INR0.8%-660.8 INR--140.4KOff
8 May 2026632.0 INR2.7%-661.9 INR--56.2KOff
1 May 2026615.6 INR4.9%-663.2 INR--30.1KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.